Clinical Trial Detail

NCT ID NCT03575819
Title A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Fortis Therapeutics, Inc.
Indications

prostate cancer

Therapies

FOR46

Age Groups: adult senior

No variant requirements are available.